Healios K.K. (OTCMKTS:HLOSF – Get Free Report) was the target of a large drop in short interest during the month of March. As of March 31st, there was short interest totaling 417,084 shares, a drop of 17.1% from the March 15th total of 502,899 shares. Based on an average daily trading volume, of 667 shares, the days-to-cover ratio is presently 625.3 days.
Healios K.K. Price Performance
Shares of Healios K.K. stock opened at $2.30 on Friday. The business’s 50 day simple moving average is $2.34 and its 200 day simple moving average is $2.67. Healios K.K. has a 52-week low of $1.90 and a 52-week high of $4.45.
About Healios K.K.
Healios K.K. is a Tokyo–based biotechnology company focused on the development and commercialization of regenerative medicine products and services. The company’s core expertise lies in induced pluripotent stem cell (iPSC)–derived therapies, with a pipeline that includes retinal pigment epithelium (RPE) cells for age‐related macular degeneration and neural cell products targeting neurological disorders. Healios operates a specialized cell processing center in Chuo‐ku, Tokyo, adhering to stringent quality standards for clinical‐grade cell manufacturing.
Beyond its proprietary programs, Healios provides contract development and manufacturing services (CDMO) to pharmaceutical and research institutions.
Read More
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
